- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 307/38 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
Patent holdings for IPC class C07D 307/38
Total number of patents in this class: 92
10-year publication summary
|
12
|
5
|
9
|
8
|
13
|
4
|
6
|
4
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ADT Pharmaceuticals, LLC | 14 |
8 |
| Nederlandse Organisatie voor Toegepast-natuurwetenschappelijk Onderzoek TNO | 2378 |
4 |
| Neem Biotech Limited | 12 |
4 |
| Sanford Burnham Prebys Medical Discovery Institute | 278 |
3 |
| Eisai R&D Management Co., Ltd. | 1274 |
3 |
| Glaxo Group Limited | 4281 |
2 |
| BASF SE | 20432 |
2 |
| Arrow Therapeutics Limited | 14 |
2 |
| Neste Oyj | 727 |
2 |
| Epiodyne, Inc. | 7 |
2 |
| Origin Materials Operating, Inc. | 55 |
2 |
| F. Hoffmann-La Roche AG | 7942 |
1 |
| Conopco, Inc. | 4808 |
1 |
| E. I. du Pont de Nemours and Company | 4249 |
1 |
| AstraZeneca AB | 2958 |
1 |
| Mars, Incorporated | 2916 |
1 |
| Merck Patent GmbH | 5842 |
1 |
| Bayer Intellectual Property GmbH | 2569 |
1 |
| Bayer Pharma AG | 1085 |
1 |
| Amgen Inc. | 3899 |
1 |
| Other owners | 49 |